Estradiol in Men: What It Actually Does

A man builds estradiol out of his own testosterone. A lot of what testosterone gets credit for is estradiol doing the work. In reality, about half the benefit of testosterone comes from its conversion to estradiol, and about half from its conversion to DHT.

Most men have never been told they make estradiol at all. Some have been told their level came back high and should be brought down.

A man does not get estradiol from anywhere else. An enzyme called aromatase builds it out of his own testosterone, mostly outside the testicles: in fat, bone, brain and blood vessel walls.

So when a man starts testosterone and his estradiol rises, nothing got into him. His estradiol is made from his testosterone.

This is what it does for him, and why I give some men more.

One note on words. Estrogen on its own means conjugated equine estrogen, the horse-derived mixture. Estradiol means the bioidentical molecule a human body makes for itself, 17-beta estradiol. Older papers use estrogens as a catch-all for everything a body makes, a third meaning again.

It holds a man's skeleton together

A thirty-one-year-old man walked in still growing. His growth plates had never closed, his bones hurt, his testosterone was normal. He was born without a working aromatase gene, so he made almost no estradiol.

Six months of testosterone by injection moved nothing: not the bone age, not the pain, not the plates.

Then estradiol through the skin. The pain was gone by six months. His spine bone density climbed from 0.93 to 1.05 to 1.17. At nine months the growth plates finally closed.

A second man in another country was treated in stages. Testosterone alone barely moved his bone, estradiol alone did more, both together did the most. Their conclusion: testosterone needs estrogens standing next to it to build bone in a man.

The mirror. A twenty-eight-year-old man, growth plates still open. His estradiol was not low. It was high. The receptor that reads it was broken, so ethinyl estradiol raising his level tenfold changed nothing. One man had the receptor and no hormone, the other the hormone and no receptor, same skeleton.

Rare genetics. Now ordinary men. Sixty-nine men over sixty with borderline testosterone took a drug that blocks aromatase for a year, against placebo. Their estradiol came down a little, and their spine bone density fell 1.7 percent while placebo rose. Their own summary: they restored testosterone into the midnormal range for a healthy young man, and spine density went down anyway.

It keeps fat off his middle

Four hundred healthy men aged twenty to fifty had their own production switched off, then testosterone handed back at graded doses, with the conversion blocked in half of them.

The men who could not make estradiol gained body fat, fat under the skin, and fat inside the abdomen, packed around the organs. That last one travels with heart disease and diabetes. The authors' conclusion: estrogen deficiency primarily accounted for increases in body fat.

In seventeen other healthy men, six weeks of an aromatase blocker raised testosterone and lowered insulin sensitivity.

It is part of sex drive and erections

Same trial. The men whose conversion was blocked, on the same testosterone, wanted sex less and their erections got worse, and the erectile effect held as estradiol's own. The authors' conclusion: sexual function is regulated by both androgens and estrogens.

It helps his memory and holds his hot flashes down

Thirty-nine men aged fifty to ninety got identical testosterone for six weeks, estradiol allowed to rise in one group and halved in the other. Verbal memory improved only where estradiol rose.

Men get hot flashes too, and it is mostly an estradiol problem. In two back-to-back trials, identical except that the second blocked the conversion, the blocked men reported hot flashes at thirty-five percent of visits against twenty-six.

The same test, run at scale

Men treated for prostate cancer have their testosterone taken away on purpose, and more than eighty percent of their estradiol goes too. Then the familiar list, as one 2024 review assembles it: bone loss inside twelve weeks, hot flashes in eight in ten, weight gain, low mood, memory complaints, and, in claims data reported inside Kintzel, more diabetes.

This year the trialists who ran the biggest test put the other reading in print: the estradiol loss causes many of the adverse events blamed on the treatment.

A British trial ran the control in 1,360 men, the standard injection against an estradiol patch. Both drove testosterone down, cancer control held, and hot flashes ran at half the rate on the patch.

What I actually do with this

A man on testosterone whose estradiol rises is doing the conversion he was built to do. I might check an estradiol at baseline. Once he is on testosterone, I do not. It is going to be high, that is the point of it, and the only thing the number reliably produces is a worried patient. He tells me more than the number ever will.

In men who are metabolically wrecked, carrying visceral and belly fat with lipids and insulin going the wrong way, I add oral estradiol on top of the testosterone, because the fat and the lipids are what I am treating.

Here is the footing. The trials that isolate estradiol take it away, and fat, glucose, bone and memory get worse. It has been added back elsewhere, in men whose own production was already switched off, the one thing they share with a man on testosterone. Oral estradiol cut bone breakdown by about a third in a randomized, placebo-controlled trial. A second raised HDL and lowered blood pressure in seven men over eight weeks. A bigger add-back trial in the same kind of men missed its main bone-density target and improved bone strength. That one used a 0.1 percent transdermal gel, and I would not expect much bone out of a low-strength gel that is poorly absorbed through the skin.

What it means

It does not mean more is better or that a number tells you what to do. Estradiol is not something a man's testosterone is contaminated with. It is a large part of what his testosterone is for. His bones hold, his memory works, he still wants his spouse, and three of those were tested by randomizing the conversion itself in men taking testosterone. Every man who lost it showed us what it had been holding up.

The whole argument:

Wondering instead whether estradiol is what hurts men on testosterone? That has its own episode: Stop Settling for Normal, Why Did This Estradiol Go Up?

⚠️ Educational content, not individual medical advice, diagnosis or a treatment recommendation. Nothing here tells any man what to take, and nobody should start, stop or change a prescription because of an article. Your own labs and history belong in a one on one.

🩺 DNP led telehealth hormone optimization. Book a consultation and find everything: withinyou.health/links

Sources

Burnett-Bowie SM, et al. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. J Clin Endocrinol Metab. 2009;94(12):4785-4792.

Carani C, et al. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med. 1997;337(2):91-95.

Cherrier MM, et al. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology. 2005;64(2):290-296.

Coelingh Bennink HJT, et al. The loss of estradiol by androgen deprivation in prostate cancer patients shows the importance of estrogens in males. J Endocr Soc. 2024;8(7):bvae107.

Finkelstein JS, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013;369(11):1011-1022.

Gibb FW, et al. Aromatase inhibition reduces insulin sensitivity in healthy men. J Clin Endocrinol Metab. 2016;101(5):2040-2046.

Kintzel PE, et al. Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer. Pharmacotherapy. 2008;28(12):1511-1522.

Komesaroff PA, et al. Low-dose estrogen supplementation improves vascular function in hypogonadal men. Hypertension. 2001;38(5):1011-1016.

Langley RE, et al. Transdermal estradiol patches in locally advanced prostate cancer. N Engl J Med. 2026;394(16):1595-1607.

Rochira V, et al. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone. Bone. 2007;40(6):1662-1668.

Russell N, et al. Effects of estradiol on bone in men undergoing androgen deprivation therapy: a randomized placebo-controlled trial. Eur J Endocrinol. 2022;187(2):241-256.

Smith EP, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994;331(16):1056-1061.

Taxel P, et al. The effect of micronized estradiol on bone turnover and calciotropic hormones in older men receiving hormonal suppression therapy for prostate cancer. J Clin Endocrinol Metab. 2002;87(11):4907-4913.

Taylor AP, et al. Effects of testosterone and estradiol deficiency on vasomotor symptoms in hypogonadal men. J Clin Endocrinol Metab. 2016;101(9):3479-3486.